Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticop: Corticosteroids vs Placebo in Severe COPD Exacerbations
NCT04163536Phase 3Completed
- Sponsor
- Centre Hospitalier de Versailles
- Start
- Oct 2021
- Primary completion
- Nov 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone injection in chronic obstructive pulmonary disease (COPD), sponsored by Centre Hospitalier de Versailles. Started Oct 2021; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04163536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04163536.